These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34244176)

  • 41. Covid-19: Use social media to maximise vaccine confidence and uptake.
    Patten D; Green A; Bown D; Russell C
    BMJ; 2021 Jan; 372():n225. PubMed ID: 33500243
    [No Abstract]   [Full Text] [Related]  

  • 42. Rising to the challenge: a COVID-19 vaccination service for the housebound population.
    Murphy P
    Br J Community Nurs; 2021 Jul; 26(7):328-333. PubMed ID: 34232712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public health experts are learning from Canada's anti-mask protests.
    Hapuhennedige S
    CMAJ; 2020 Oct; 192(42):E1274-E1275. PubMed ID: 33077526
    [No Abstract]   [Full Text] [Related]  

  • 44. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
    John TJ; Dharmapalan D
    Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial Intelligence Model of Drive-Through Vaccination Simulation.
    Asgary A; Valtchev SZ; Chen M; Najafabadi MM; Wu J
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33396526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Skjefte M; Ngirbabul M; Akeju O; Escudero D; Hernandez-Diaz S; Wyszynski DF; Wu JW
    Eur J Epidemiol; 2021 Feb; 36(2):197-211. PubMed ID: 33649879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.
    Gray G; Van der Heever A; Madhi SS; McIntyre J; Kana B; Stevens W; Sanne I; Richards G; Abdullah F; Mendelson M; Dasoo A; Nel J; Wulfsohn A; Blumberg L; Venter F
    S Afr Med J; 2020 Dec; 0(0):13163. PubMed ID: 33334389
    [No Abstract]   [Full Text] [Related]  

  • 49. Building global capacity for COVID-19 vaccination through interactive virtual learning.
    Goldin S; Hood N; Pascutto A; Bennett C; Barbosa de Lima AC; Devereaux N; Caric A; Rai K; Desai S; Lindstrand A; Struminger B
    Hum Resour Health; 2022 Feb; 20(1):16. PubMed ID: 35120542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implications of anesthesia and vaccination.
    Lin C; Vazquez-Colon C; Geng-Ramos G; Challa C
    Paediatr Anaesth; 2021 May; 31(5):531-538. PubMed ID: 33540468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
    Dal-Ré R; Orenstein W; Caplan AL
    Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19 vaccination in incapacitated, unrepresented patients.
    Bergman J; Fero KE; Schneider PL
    J Am Geriatr Soc; 2021 Jun; 69(6):1454-1456. PubMed ID: 33742696
    [No Abstract]   [Full Text] [Related]  

  • 55. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Public Perspectives on COVID-19 Vaccine Prioritization.
    Persad G; Emanuel EJ; Sangenito S; Glickman A; Phillips S; Largent EA
    JAMA Netw Open; 2021 Apr; 4(4):e217943. PubMed ID: 33835172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Support Pharmacy Infrastructure to Strengthen US COVID-19 Vaccination Efforts and Beyond.
    Marwitz KK; Haugtvedt C; Kostrzewa AB
    Am J Public Health; 2021 Jul; 111(7):1204-1206. PubMed ID: 34370541
    [No Abstract]   [Full Text] [Related]  

  • 58. Delayed COVID-19 vaccine roll-out in Japan.
    Kosaka M; Hashimoto T; Ozaki A; Tanimoto T; Kami M
    Lancet; 2021 Jun; 397(10292):2334-2335. PubMed ID: 34089658
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19 anti-vaccine movement and mental health: Challenges and the way forward.
    Ransing R; Dashi E; Rehman S; Chepure A; Mehta V; Kundadak GK
    Asian J Psychiatr; 2021 Apr; 58():102614. PubMed ID: 33662657
    [No Abstract]   [Full Text] [Related]  

  • 60. Recovering staff, recovering services: massive-online support for recovering a paediatric service using Lean and compassionate communication.
    Smith IM; Bayliss E
    BMJ Open Qual; 2022 Jun; 11(2):. PubMed ID: 35750350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.